The different TP53 RNA transcripts play distinct biological roles and in breast cancer, the TP53β 3′ end levels have been negatively associated with tumor size, and positively associated with estrogen receptor (ER) positive tumors and better patient outcomes [14,15]. This evidence concerns the gene TP53 and breast carcinoma.